Skip to main content

Table 3 Resource use

From: Intensive care–treated cardiac arrest: a retrospective study on the impact of extended age on mortality, neurological outcome, received treatments and healthcare-associated costs

 

Age < 75 (n = 1073)

Age ≥75 (n = 212)

p

Cost of treatments in €, median (IQR)

   

 Hospital costs

29 971 (13 381 − 50 212)

18 356 (9 740 − 37 102)

< 0.001

 Rehabilitation

0 (0–6 543)

0 (0–7 574)

0.928

 Social Insurance Institution

1 669 (579-6 686)

714 (392-1 760)

< 0.001

Cost of treatment of those with CPC 1–2 after 12 months in €, median (IQR) (57 %)

   

 Hospital

41 194 (27 031–63 709)

34 888 (19 083 − 60 029)

0.071

 Rehabilitation

2113 (0–9 603)

6073 (417 − 13 319)

0.012

 Social Insurance Institution

4 561 (1 173 − 15 043)

2 049 (1 196-3 509)

< 0.001

Total cost in €, median (IQR)

   

 Everyone

38 195 (16 505-71680)

22 641 (12 488 − 47 006)

< 0.001

 Those with CPC 1–2 after 12 months (57)

54 510 (36 148 − 86 461)

39 482 (24 101 − 93 020)

0.040

Effective costa in €

   

 Of those with CPC 1–2 after 12 months

119 941

168 416

-

Effective cost in € among those with CPC 1–2 after 12 months

   

 OHCA

90 499

133 134

-

 IHCA

161 670

199 540

-

 ICUCA

308 000

172 595

-

  1. aEffective cost: The total healthcare-associated costs of all patients within their respective age group divided by the number of survivors with a favourable neurological outcome